Seeking Alpha

Shares of Celsion (CLSN) added to yesterday's 79% free fall today, closing out the day with an...

Shares of Celsion (CLSN) added to yesterday's 79% free fall today, closing out the day with an additional 12.6% hit after touching a new 52-week low of $1.25 earlier. The downturn was sparked on Thursday after the company announced that ThermoDox did not meet the primary endpoint in a Phase III study in patients with hepatocellular carcinoma also known as primary liver cancer.
Comments (4)
  • barnsey
    , contributor
    Comments (252) | Send Message
     
    With nothing else in the pipeline, still wondering why it trades over a dollar.
    1 Feb 2013, 05:29 PM Reply Like
  • depueman
    , contributor
    Comments (102) | Send Message
     
    Primarily because they are looking through the results to see if a subset of patients was helped more than others, at least that is how I understand it. Seems pretty far fetched I must say.
    2 Feb 2013, 08:17 AM Reply Like
  • pumarega
    , contributor
    Comments (7) | Send Message
     
    It will trade under eventually. Shorts are covering their gains, which adds to bid volume. Give it a couple more trading days.
    4 Feb 2013, 10:24 AM Reply Like
  • Bronco75
    , contributor
    Comment (1) | Send Message
     
    Is there hope for celsion
    5 Feb 2013, 09:43 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|